Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients
- 1 March 1991
- journal article
- research article
- Published by Springer Science and Business Media LLC in Calcified Tissue International
- Vol. 49 (2), 71-76
- https://doi.org/10.1007/bf02565124
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Bone loss in response to long-term glucocorticoid therapyBone and Mineral, 1990
- The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjectsMetabolism, 1988
- Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1983
- SINGLE VERSUS DUAL ENERGY CT FOR VERTEBRAL MINERAL QUANTIFICATIONJournal of Computer Assisted Tomography, 1983
- Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapyMetabolism, 1983
- CORTICOSTEROID‐INDUCED OSTEOPENIA AND VITAMIN D METABOLISM. EFFECT OF VITAMIN D2, CALCIUM PHOSPHATE AND SODIUM FLUORIDE ADMINISTRATIONClinical Endocrinology, 1982
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982
- Bone loss in adults receiving alternate day glucocorticoid therapyArthritis & Rheumatism, 1981
- Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.JCI Insight, 1980
- Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosisMetabolic Bone Disease and Related Research, 1979